However, for the rs12766939 in the CUBILIN gene with the major homozygote as reference, the hazard ratio for mortality for the minor homozygote genotype was 1.17 (1.06 -1.29), P < 0.002. This should be viewed with caution, as rs12766939 was not in Hardy-Weinberg equilibrium. In conclusion, our study confirms a probable causal but weak relation between serum 25(OH)D level and mortality. The relation between rs12766939 and mortality needs confirmation in more homogenous cohorts.
Introduction
The nuclear vitamin D receptor (VDR) is found in most tissues of the body, and enzymes necessary for the activation of vitamin D to 25-hydroxyvitamin D (25(OH)D), and finally to 1,25-dihydroxyvitamin D (1,25(OH)2D), are located not only in the liver and kidneys, but in peripheral tissues as well. Vitamin D is essential for calcium absorption and bone health, but may also have a number of other biological functions, in particular related to cell proliferation and immunology [1] .
Low serum levels of 25(OH)D, which is used as a marker of the body´s vitamin D stores, are associated with cardiovascular risk factors like hypertension, hyperglycaemia and J o u r n a l P r e -p r o o f hyperlipidaemia, as well as manifest diseases like cancer, type 2 diabetes, cardiovascular and immunological diseases [2] . It has, however, been difficult to show a beneficial effect of vitamin D supplementation in treatment or prevention of these diseases in randomized, controlled trials (RCTs), possibly because most of those included have not been in need of supplementation as their 25(OH)D status has been more than adequate [3, 4] . There are also ethical problems with including vitamin D deficient subjects for an extended period of time, and one may therefore not get the final answer regarding vitamin D supplementation from RCTs.
Another approach is the Mendelian randomization (MR) procedure [5] , and there are several single nucleotide polymorphisms (SNPs) related to enzymes needed for activation, transport and breakdown of vitamin D, as well as in the VDR. However, the results have not consistently been in favour of vitamin D. Thus, SNPs related to synthesis and breakdown of 25(OH)D have been associated with type I diabetes [6] , hypertension [7] and multiple sclerosis One explanation could be that the effect of vitamin D is modest (if present at all), and therefore a large number of subjects are needed to show an effect on specific diseases. On the other hand, if there is a broad-ranging effect of vitamin D as indicated by the overwhelmingly positive effect in observational studies and the wide-spread localization of the VDR, one would assume that this would add up to an increased mortality risk in those with vitamin D deficiency that would be more easy to demonstrate [14] .
A relation to mortality has also been found in meta-analyses of vitamin D RCTs [15, 16] , but none of the included studies were specifically designed for that purpose. Similarly, in a large MR study using SNPs associated to the serum 25(OH)D level, genetically low 25(OH)D J o u r n a l P r e -p r o o f was related to mortality [17] , but more studies were asked for [18] . There are also a few MR studies on mortality using VDR SNPs, but these have been too small to draw firm conclusions [19] [20] [21] .
We have previously reported a lack of significant association between 25(OH)D related SNPs and mortality in 9528 subjects followed for up to 15 years in the Tromsø study [22] .
Furthermore, 4465 of these subjects have been included in a Mendelian randomization analysis on vitamin D and mortality combining three European cohorts [23] , and 7145 of the subjects in a meta-analysis on standardized serum 25(OH)D and mortality including eight European cohorts [24] . Since then we have genotyped additional subjects, included genotyping of VDR, MEGALIN and CUBILIN SNPs, and the observation period is now up to 22 years. In view of the uncertainty regarding vitamin D and mortality, we therefore found it worthwhile to reanalyse the cohort for vitamin D SNPs and mortality.
Methods

Subjects
The Tromsø study is a repeated population-based study conducted in the municipality of Tromsø, Norway, situated at 69°N (current population 76 000). The study was initiated in 1974, and has been performed seven times at regular intervals. The seventh and latest survey was conducted in 2015-2016. In the fourth survey in 1994-1995, all individuals aged 25 years or older and living in Tromsø were invited. A total number of 27 158 persons participated in the first visit, providing an attendance rate of 77%. All men aged 55-74 years, all women aged 50-74 years and a sample of 5-10% of the remaining age groups between 25 and 84 years were invited to a second visit with more extensive clinical examination, and 7965 persons, or 78% of those invited, attended [25] . The study was conducted by UiT The Arctic University of Norway in cooperation with the National Health Screening Service. For this cohort of 27 158 J o u r n a l P r e -p r o o f subjects, specific endpoint registers for myocardial infarction, type 1 diabetes, stroke, hip and radial fractures, and aortic stenosis have been created. In addition, data from the Cancer Registry of Norway and the National Causes of Death Registry were available. In our initial report in 2012, subjects with one or more of these endpoints plus a randomly selected control group were included, and all together 9528 subjects were genotyped [22] . For the present study, subjects who met to the second visit of the fourth survey and who were not genotyped in 2012 (n = 2369), were now included and genotyped for the same SNPs as the initial cohort. In addition, all subjects were also genotyped for several new SNPs.
Measurements
At the survey in 1994-1995, the participants filled in questionnaires on medical history and lifestyle factors. Blood pressure, height and weight, serum total cholesterol and triglycerides were measured and analyzed as previously described [22] . Sera from the second 
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Statistical analyses
The relations between SNP genotypes, and mortality were evaluated in Cox regression analyses with age and gender as covariates and with the major homozygote genotype used as The genotype frequencies were examined for compliance with Hardy-Weinberg equilibrium using chi-squared analysis [29] . Linkage disequilibrium (LD) between SNPs was evaluated with r 2 and Lewontin's D′ statistics [30, 31] .
The data are shown as mean ± SD. All tests were done two-sided, and a P-value < 0.05 was considered statically significant. The P-values are shown without corrections for multiple comparisons.
Ethics
The study was approved by the Regional Committee for Medical and Health Research Ethics (REK Nord) (reference 2010/2913-4). Only participants with valid written consent were included.
Results
J o u r n a l P r e -p r o o f
Baseline
A total of 11 897 subjects had at least one SNP successfully analyzed, 5347 (44.9%) men and 6550 (55.1%) women, and were included in the analyses. Among these, 33.7 % were current smokers at baseline. In 1994-1995 their mean ± SD age was 57.8 ± 13.6 years and BMI 25.9 ± 4.1 kg/m 2 .
The individual SNP analyses were successful in 98.8-99.5% of the subjects. The genotypes for all the SNPs were in Hardy-Weinberg equilibrium except for rs12766939 in the CUBILIN gene (Chi square 8.36, P < 0.01), and rs12785878 in the NADSYN1 gene (Chi square 7.97, P < 0.01). The VDR SNPs rs7975232 (Apa1), rs1544410 (Bsm1), and rs731236 (Taq1) were in LD with each other (r 2 > 0.4) and also with rs2239179 and rs7968585 (r 2 > 0.4).
Rs2239179 and rs7968585 were in moderate LD (r 2 = 0.386). None of the other SNPs (including rs2228570 (Fok1)) were in LD.
Among the 11 897 subjects, serum 25(OH)D was analyzed in 6733 subjects. The mean (Table 1) . These score predicted 0.3 and 1.8 %, respectively, of the variation in the serum 25(OH)D levels.
There were no statistically significant differences between the genotypes regarding age and gender, smoking status, systolic blood pressure or serum cholesterol. However, for the 25(OH)D synthesis genetic score, there was a significant association with serum triglycerides with the highest triglyceride levels in those with the highest genetic score (lowest serum 25(OH)D) (linear trend, P = 0.023).
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Subjects in the lowest serum 25(OH)D percentile group had higher BMI, systolic blood pressure and serum triglyceride levels than those in higher serum 25(OH)D percentiles (linear trend, P < 0.001) ( Table 1) .
Cox regression
During the observation period 5491 subjects (2762 men and 2729 women) had died. In the Cox regression analysis, only the CUBILIN SNP rs12766939, the 25(OH)D synthesis genetic score, and the serum 25(OH)D percentile groups were significantly associated with mortality ( [21] . To our knowledge our study is therefore the largest where these SNPs have been analyzed in relation to mortality, but the results were negative.
We also included two other VDR SNPs (rs2239179 and rs7968585) since they in a study
by Levin et al. were found to modify the association between serum 25(OH)D and a composite outcome consisting of hip fracture, myocardial infarction, cancer and mortality [25] . However, we could not find an association between these SNPs and mortality, nor did we find an interaction with low serum 25(OH)D levels. This is in agreement with the studies by OrdonezMena et al. [38] and Vimaleswaran et al. [44] . Even though the concept of interaction between an altered VDR receptor and vitamin D deficiency is appealing, this still needs supportive data. Again, we could not confirm such interactions, but the CUBILIN SNP rs12766939 was significantly associated with mortality, which to our knowledge has not been reported before.
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It should be noted though that this SNP, similar to rs12785878 in the NADSYN1 gene, was not Weinberg equilibrium. The results should therefore be interpreted with caution, and the relation between the CUBILIN SNP rs12766939 and mortality (which was highly significant even after Bonferroni correction) should be considered as exploratory.
Our study also has strengths. It is, to our knowledge, the largest on VDR, CUBILIN and MEGALIN SNPs and mortality, and the results regarding the 25(OH)D synthesis genetic score are in line with similar studies.
In conclusion, the questions regarding vitamin D and mortality are still unanswered.
Although MR studies also have their limitations [5] , discovery of SNPs more strongly related to serum 25(OH)D levels and SNPs with direct effects on the function of the VDR, might hopefully bring us closer to an answer. J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f * Sum of NADSYN1 rs12785878 and CYP2R1 rs10741657 scores where the allele with the highest 25(OH)D is given a score of 1, the homozygote 2, and the allele with the lowest 25(OH)D a score of 3; ** Sum of GC rs2298850 and rs7041 and CYP24A1 rs6013897 scores where the where the allele with the highest 25(OH)D is given a score of 1, the homozygote 2, and the allele with the lowest 25(OH)D a score of 3; *** Month of blood sampling specific, calculated for smokers and non-smokers separately
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